Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > I/O 360 feb23
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Jthom376on Jan 16, 2023 8:50am
249 Views
Post# 35225242

RE:RE:I/O 360 feb23

RE:RE:I/O 360 feb23Re. DLBCL data...assume it's solid but not amazing. Good enough to continue justifying. Not good enough to have lasting change in SP.... probably cause a pop allowing for ATM release. Assumption based upon IMV doing a awful financing in December. Why do that deal if you have amazing data to release... yup... that to me is more telling than any of their data. Bad deals on bad deals
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities